NOTE: By submitting this form and registering with us, you are providing us with permission to store your personal data and the record of your registration. In addition, registration with the Medical Independent includes granting consent for the delivery of that additional professional content and targeted ads, and the cookies required to deliver same. View our Privacy Policy and Cookie Notice for further details.

You can opt out at anytime by visiting our cookie policy page. In line with the provisions of the GDPR, the provision of your personal data is a requirement necessary to enter into a contract. We must advise you at the point of collecting your personal data that it is a required field, and the consequences of not providing the personal data is that we cannot provide this service to you.

Don't have an account? Subscribe

‘Realistic’ pay for CEO position ‘not foreseen’, noted Beaumont’s board

By Catherine Reilly - 24th Apr 2019

The board at Beaumont Hospital in Dublin has noted that achieving “a realistic rate of remuneration” to recruit for a CEO is not foreseen.

The comment was included in board chairperson Mr Enda Connolly’s correspondence to the HSE National Director of Acute Operations Mr Liam Woods in June. He informed Mr Woods the board wanted to reach agreement with the HSE on a longer-term arrangement for Mr Ian Carter to continue in the CEO position at Beaumont.

As recently reported in the Medical Independent (MI), Mr Carter will remain as Beaumont CEO until the end of 2020.

Mr Carter was appointed as Beaumont’s interim CEO in June 2016 after the early retirement of the previous incumbent. This appointment was made following pressure from the HSE, which doubted a recruitment campaign for the €121,000 salary would be successful. Mr Carter took up the post for no extra pay and at least a 60 per cent time commitment, MI was informed at the time.

The appointment was controversial, as Mr Carter heads the RCSI Hospitals Group, which includes Beaumont. In his letter to Mr Woods, however, the hospital chairperson said the board’s experience of Mr Carter’s management of Beaumont had been “very positive”.

It proposed an amended arrangement that included appointing Mr Carter for a further three years from 1 October 2018. The letter outlined that Mr Carter would continue in the position in tandem with heading RCSI Hospitals, “provided he has sufficient time to fulfil both roles”.

As hospital CEO, Mr Carter would give account for Beaumont’s activities and performance to the National Director of Acute Operations. Should conflicts between the respective responsibilities arise, the board would expect the CEO to bring the matter to the attention of the board chairperson.

In a preliminary response, Mr Woods informed Mr Connolly that “the initial observation is that Mr Carter’s HSE contract end date is 31 December 2020 and the extension cannot exceed the duration of any HSE contract held by the individual as RCSI Hospital Group CEO, or any other HSE contract held by him before taking up the RCSI HG CEO post”.

On 20 September, Mr Woods wrote to confirm his agreement to extend Mr Carter’s appointment at Beaumont to 31 December 2020.

Leave a Reply

Latest Issue
The Medical Independent 20th February
The Medical Independent 20th February 2024

You need to be logged in to access this content. Please login or sign up using the links below.

Most Read